Nectar Lifesciences completes sale of API and formulations business

12 Nov 2025 Evaluate

Nectar Lifesciences has completed the slump sale of its active pharmaceutical ingredients (API) and formulations business (Business) to Ceph Lifesciences in accordance with the terms of the business transfer agreement (BTA). The company has also completed the asset sale to Ceph Lifesciences. The transfer is completed with effect from November 10, 2025. 

Incorporated in 1995, Nectar Lifesciences is a leading global manufacturer of cephalosporin antibiotics medicines.

Nectar Lifesciences Share Price

14.76 0.18 (1.23%)
23-Jan-2026 12:25 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1637.50
Dr. Reddys Lab 1242.30
Cipla 1381.95
Zydus Lifesciences 887.65
Lupin 2145.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×